From Relypsa Gets Another $50M for Drug to Fight Excess Potassium:

relypsa

relypsa—

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Webinar
Digitization of the Regenerative Medicine Supply Chain
An overview of the evolving regenerative medicine supply chain and its requirements, challenges, and opportunities
Global OT/IT – Quality Services

Sponsored · Webinar
July 21 – The Need for Manufacturing Execution Systems (MES) in Cell and Gene Therapy
A discussion on business drivers, technical considerations, special requirements of cell and gene product manufacturing & digitization strategy
Global OT/IT Quality Services

Xconomy on Demand

We offer a number of ways to subscribe for free!